Andrew Derodra

Keine laufenden Positionen mehr

59 Jahre

Health Technology

Consumer Non-Durables

Consumer Services

Profil

Andrew Derodra served as the Chief Financial Officer & Executive Director at SkyePharma Plc and as the Director-Business Transformation at ABI SAB Group Holding Ltd. He also worked as the Vice President-Finance & Control at Tate & Lyle Plc.
From 2016 to 2018, he served as the Chief Financial Officer & Director at Vectura Group Ltd. Mr. Derodra completed his undergraduate degree at the University of Oxford.

Ehemalige bekannte Positionen von Andrew Derodra

Unternehmen	Position	Ende
VECTURA GROUP	Finanzdirektor/CFO	31.07.2018
SABMILLER PLC	Corporate Officer/Principal	-
TATE & LYLE PLC	Corporate Officer/Principal	-
SKYEPHARMA PLC	Finanzdirektor/CFO	-

Sehen Sie sich die Erfahrung von Andrew Derodra im Detail an

Ausbildung von Andrew Derodra

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andrew Derodra im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
SkyePharma Plc SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products	Health Technology
ABI SAB Group Holding Ltd. ABI SAB Group Holding Ltd. Beverages: AlcoholicConsumer Non-Durables Engages in manufacturing and distributing beers and beverages	Consumer Non-Durables
Vectura Group Ltd. Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices	Health Technology
Tate & Lyle Plc Tate & Lyle Plc Food: Specialty/CandyConsumer Non-Durables Manufactures sweeteners, industrial starches and ingredients	Consumer Non-Durables
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services